STAT+: Medicare’s miss on Alzheimer’s drug spending

Medicare's predicted spending on Alzheimer's drug Leqembi was $3.5 billion in 2025, but the actual cost is expected to be higher. The prediction was made by Medicare's actuaries two years ago. The article discusses the discrepancy in the predicted and actual costs.